Outcomes and characteristics of patients on protease inhibitors at a tertiary level antiretroviral clinic
Background: Protease inhibitors (PIs) have been recommended as World Health Organization second-line antiretroviral therapy (ART) for low- to middle-income countries for two decades. As dolutegravir-based regimens have become widely available, the future role of PIs is uncertain. Objectives: To desc...
Saved in:
Main Authors: | Michele Perks (Author), Denasha L. Reddy (Author), Francois Venter (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study
by: Damalie Nalwanga, et al.
Published: (2021) -
Association Between HIV in Pregnancy and Antiretroviral Therapy, Including Protease Inhibitors and Low Birth Weight Infants
by: Phillip J. Goldstein, et al.
Published: (2000) -
Fasciola hepatica serine protease inhibitor family (serpins): Purposely crafted for regulating host proteases.
by: Carolina De Marco Verissimo, et al.
Published: (2020) -
Characteristics and outcomes of older people on antiretroviral therapy in Tlokwe Clinics, South Africa
by: Mareike Rabe, et al.
Published: (2020) -
Oral candidiasis in HIV+ patients under treatment with protease inhibitors
by: Andréa Lusvarghi Witzel, et al.
Published: (2008)